We are live on ! Find out more
ADVM

Adverum Biotechnologies
ADVM

Delisted

ADVM was delisted on the 8th of December, 2025.

Back to rankings

99 hedge funds and large institutions have $267M invested in Adverum Biotechnologies in 2019 Q3 according to their latest regulatory filings, with 26 funds opening new positions, 35 increasing their positions, 21 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed

67% more repeat investments, than reductions

Existing positions increased: 35 | Existing positions reduced: 21

24% more first-time investments, than exits

New positions opened: 26 | Existing positions closed: 21

5% more funds holding

Funds holding: 94 → 99 (+5)

9% more call options, than puts

Call options by funds: $7.25M | Put options by funds: $6.68M

0.33% more ownership

Funds ownership: 7.27% → 7.6% (+0.33%)

51% less capital invested

Capital invested by funds: $549M → $267M (-$282M)

100% less funds holding in top 10

Funds holding in top 10: 3 → 0 (-3)

Holders
99
Holders Change
+5
Holders Change %
+5.32%
% of All Funds
2.17%
Holding in Top 10
–
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-100%
% of All Funds
–
New
26
Increased
35
Reduced
21
Closed
21
Calls
$7.25M
Puts
$6.68M
Net Calls
+$569K
Net Calls Change
+$196K

Top Buyers

Rank Fund Capital Flow
1
State Street
State Street
Massachusetts
+$37.5M
2
O
OrbiMed
New York
+$23.1M
3
GTC
Ghost Tree Capital
New York
+$16.3M
4
Citadel Advisors
Citadel Advisors
Florida
+$9.26M
5
ACA
Avoro Capital Advisors
New York
+$8.45M

Top Sellers

Rank Fund Capital Flow
1
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$22.5M
2
JP Morgan Chase
JP Morgan Chase
New York
-$18.6M
3
ACP
Acuta Capital Partners
California
-$14.1M
4
Renaissance Technologies
Renaissance Technologies
New York
-$13.1M
5
UBS Group
UBS Group
Switzerland
-$9.67M
Name Holding Trade Value Shares
Change 		Change in
Stake
Morgan Stanley
26
Morgan Stanley
New York
$1.63M +$3.18M +28,220 +1,618%
Norges Bank
27
Norges Bank
Norway
$1.34M +$1.66M +14,685 +148%
D.E. Shaw & Co
28
D.E. Shaw & Co
New York
$1.25M +$1.09M +9,632 +72%
N
29
Nuveen
North Carolina
$1.15M -$45.2K -401 -2%
Squarepoint
30
Squarepoint
New York
$1.09M +$2.1M +18,667 +1,333%
Bank of New York Mellon
31
Bank of New York Mellon
New York
$1.05M -$764K -6,780 -26%
Citigroup
32
Citigroup
New York
$1.05M +$1.49M +13,234 +221%
BCM
33
Bluefin Capital Management
New York
$897K +$1.85M +16,452 New
California Public Employees Retirement System
34
California Public Employees Retirement System
California
$731K +$946K +8,394 +168%
CM
35
Caption Management
Oklahoma
$681K +$1.41M +12,480 New
RPAM
36
Rhenman & Partners Asset Management
Sweden
$652K – – –
Voloridge Investment Management
37
Voloridge Investment Management
Florida
$632K +$1.31M +11,596 New
Two Sigma Investments
38
Two Sigma Investments
New York
$619K +$1.28M +11,363 New
PVI
39
Pura Vida Investments
New York
$545K +$1.13M +10,000 New
California State Teachers Retirement System (CalSTRS)
40
California State Teachers Retirement System (CalSTRS)
California
$467K +$44.6K +396 +5%
Deutsche Bank
41
Deutsche Bank
Germany
$467K +$591K +5,246 +157%
PP
42
Paloma Partners
Connecticut
$454K +$938K +8,323 New
State of Wisconsin Investment Board
43
State of Wisconsin Investment Board
Wisconsin
$434K +$46.2K +410 +5%
Group One Trading
44
Group One Trading
Illinois
$404K +$572K +5,074 +217%
HT
45
HAP Trading
New York
$399K +$825K +7,319 New
RhumbLine Advisers
46
RhumbLine Advisers
Massachusetts
$395K -$1.47K -13 -0.2%
Ameriprise
47
Ameriprise
Minnesota
$384K -$1.54M -13,702 -66%
Allianz Asset Management
48
Allianz Asset Management
Germany
$383K +$793K +7,033 New
TD Asset Management
49
TD Asset Management
Ontario, Canada
$328K +$514K +4,565 +313%
Invesco
50
Invesco
Georgia
$296K -$2.74M -24,316 -82%
1
2
3 4 5

ADVM Hedge Fund Activity: Q3 2019 in Review

99 of the 4,561 institutional investors tracked by Wall St. Rank reported a position in Adverum Biotechnologies (ADVM) for Q3 2019, worth a combined $267M — down 51% from $549M a quarter earlier.

Buyers outnumbered sellers: 26 funds opened new ADVM positions and 21 closed out — a net gain of 5 holders — while 35 added to existing stakes and 21 trimmed.

The largest buyer was State Street, adding an estimated $37.5M. The largest seller was Adage Capital Partners, cutting an estimated $22.5M.

  • 99 institutional investors held Adverum Biotechnologies (ADVM) as of Q3 2019, up from 94 in Q2 2019.
  • Funds reported $267M of Adverum Biotechnologies stock for Q3 2019, down 51% quarter-over-quarter.
  • 26 funds opened new Adverum Biotechnologies positions in Q3 2019 and 21 closed out, a net change of +5 holders.
  • The largest Adverum Biotechnologies buyer in Q3 2019 was State Street, an estimated $37.5M added.
  • The largest Adverum Biotechnologies seller in Q3 2019 was Adage Capital Partners, an estimated $22.5M sold.

Based on aggregated 13F filings for Q3 2019.